tiprankstipranks
Evome Medical Reports Growth and Optimism in Q2
Company Announcements

Evome Medical Reports Growth and Optimism in Q2

Story Highlights

Salona Global Medical Device (TSE:EVMT) has released an update.

Pick the best stocks and maximize your portfolio:

Evome Medical Technologies has reported a positive second quarter in 2024 with a significant increase in Adjusted EBITDA, a rise in revenues from its core Biodex division, and a substantial reduction in debt. Under the leadership of CEO Mike Seckler, the company has seen a turnaround with successful restructuring, focusing on sales growth and cost management, and is optimistic about its future financial momentum.

For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskEvome Medical Technologies Thrives with New Strategies
TipRanks Canadian Auto-Generated NewsdeskEvome Medical Technologies Approves New Share Plan
TipRanks Canadian Auto-Generated NewsdeskSalona Global Unveils Strategic Growth Plan for Evome Medical
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App